Back
Neurocrine Biosciences Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
NBIX
Neurocrine Biosciences
Last Price:
$95.34
Seasonality Move:
8.88%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 102.3 | Sell |
| 20-day SMA: | 108.05 | Sell |
| 50-day SMA: | 119.7 | Sell |
| 200-day SMA: | 128.74 | Sell |
| 8-day EMA: | 99.72 | Sell |
| 20-day EMA: | 106.71 | Sell |
| 50-day EMA: | 115.63 | Sell |
| 200-day EMA: | 125.42 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.18 | Sell |
| Relative Strength Index (14 RSI): | 18.51 | Sell |
| Chaikin Money Flow: | -1629336 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Neurocrine Biosciences Technical Analysis
| Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 87.54 while NBIX 8-day simple moving average is 102.30, which is a Sell signal.
-
The stock price of NBIX is 87.54 while Neurocrine Biosciences 20-day SMA is 108.05, which makes it a Sell.
-
Neurocrine Biosciences 50-day simple moving average is 119.70 while NBIX share price is 87.54, making it a Sell technically.
-
NBIX stock price is 87.54 and Neurocrine Biosciences 200-day simple moving average is 128.74, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Sell
24
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a SellThe current Neurocrine Biosciences [NBIX] share price is $87.54. The Score for NBIX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
8.7B
Price in USD:
87.54
Share Volume:
2.1M
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
86.57
Sell
24
Neurocrine Biosciences (NBIX)
is a Sell
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?The Neurocrine Biosciences stock price is 87.54 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is overvalued.
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 87.54 while NBIX 8-day exponential moving average is 99.72, which is a Sell signal.
-
The stock price of NBIX is 87.54 while Neurocrine Biosciences 20-day EMA is 106.71, which makes it a Sell.
-
Neurocrine Biosciences 50-day exponential moving average is 115.63 while NBIX share price is 87.54, making it a Sell technically.
-
NBIX stock price is 87.54 and Neurocrine Biosciences 200-day simple moving average is 125.42, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.52 per share, a decrease this year of $0.40 per share, and an increase next year of $2.50 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -6.18, suggesting Neurocrine Biosciences is a Sell
-
Neurocrine Biosciences Relative Strength Index (RSI) is 18.51, which suggest Neurocrine Biosciences is oversold
-
The Bollinger Bands (25) for Neurocrine Biosciences is ( - ), which suggest Neurocrine Biosciences is a Buy
-
The Bollinger Bands (100) for Neurocrine Biosciences is ( - ), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.